Uday Kumar, MD
Fellowship Director, Global Programs
Lecturer in Bioengineering, Stanford University
Founder, President & CEO, Element Science, Inc.
Uday N. Kumar, a cardiologist and cardiac electrophysiologist (EP), and the Founder, President & CEO, Element Science, Inc., developing a cost-effective wearable therapeutic device that mitigates sudden cardiac death risk. He was formerly founder and CEO of Revive Defibrillation Systems, Inc., a company developing an innovative device for the treatment of sudden cardiac death. Uday is also a Co-Founder and current Board Member of Sympara Medical, Inc., a company developing a novel therapy for hypertension. Uday is also the Founder of iRhythm Technologies, Inc., a medical device company focused on developing cost-effective new devices and systems for cardiac rhythm monitoring. He served as a Board member and Chief Medical Officer of iRhythm from founding through broad commercialization of its Zio® Patch cardiac monitoring device, prior to joining Third Rock Ventures and founding Revive.
He serves as a Consulting Associate Professor of Bioengineering at Stanford University and is the Fellowship Director of Stanford’s Global Biodesign Programs (India and Singapore), programs that teach processes for medical innovation to solve unmet medical needs globally. Additionally, he is on the Steering Committee for Value-driven Engineering and US Global Competitiveness, an initiative focused on developing policies and recommendations to promote and retain US leadership in medical device development and innovation. He was formerly an Entrepreneur-in-Residence at Third Rock Ventures, where he focused on leading the development of new medical devices and technologies. Uday was a Biodesign fellow at Stanford, a cardiac EP and cardiology fellow at the University of California, San Francisco (UCSF), and internal medicine resident at theColumbia-Presbyterian Hospital of Columbia University. Prior to his training, Uday was Vice-President and Chief Medical Officer of Biomedical Modeling Inc., a start-up company that created rapid prototyping models from imaging data for use in numerous medical applications. Uday received his M.D. and B.A. (biochemistry and molecular biology) from Harvard University.